As the healthcare industry moves from volume to value, new healthcare delivery models are being tested and promoted, and CMS has put a lot of faith into the accountable care organization. So has Aledade.
As the healthcare industry moves from volume to value, new healthcare delivery models are being tested and promoted, and CMS has put a lot of faith into the accountable care organization (ACO). So has Aledade, a company that just celebrated its second anniversary and works to guide primary care physicians as they create and build ACOs in order to improve quality of care while bringing down costs.
Here are 5 things to know about Aledade.
1. There are some heavy hitters backing up Aledade
The company was founded by Farzad Mostashari, MD, the former National Coordinator for Health Information Technology (IT). Mostashari’s co-founders are Mat Kendall, who has years of experience working with primary care physicians on adopting and implementing electronic health record (EHR) systems, and Edwin Miller, who has developed more than 30 EHR products across healthcare.
And there is some big bucks backing Aledade, which is venture funded. In June 2015, Aledade raised a Series B Funding Round of $30 million.
2. Aledade is in 11 states
Aledade has expanded its geographic coverage with new partnerships in Nevada/Utah, Michigan, Missouri, and Pennsylvania. These 11 states cover 400 primary care physicians, and Aledade is on track to reach nearly 1000 physicians by the end of 2016, according to Mostashari.
“Together, we are taking accountability for over 100,000 patients’ care, and nearly a billion dollars of annual medical costs,” he wrote.
3. Changing how care is delivered
Nearly all (95%) of Aledade’s practices (there are more than 110 in total) provide 24/7 patient access to an on-call doctor. In addition, all of the practices offer same or next-day appointments for patients with urgent needs.
In celebration of its second anniversary, Aledade also announced that its ACOs averaged a 251% increase in preventive care visits and a 175% increase in transitional care services. This resulted in a decrease in hospital admission rates.
4. The importance of health IT
With Mostashari behind the wheel, it’s no surprise that health IT and practice interoperability is important. Aledade has joined with other leading health organizations to form the GetMyHealthData Initiative, which has commitments from organizations to take concrete steps to make it easier for patients and families to access and use health information electronically.
5. A partner, not a vendor or employer
The company partners with primary care physicians to build and lead ACOs so that the doctors can remain independent and not become employees through necessity.
“We founded Aledade on the belief that physician-led ACOs can be the leading edge of health care transformation in the United States,” Mostashari wrote in a blog post 2 years ago. “Our doctor partners share that belief and are equally eager to prove that hypothesis right.”
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More